- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Reviva Pharmaceuticals Holdings, Inc. stock price live, this page displays OTC RVPH stock exchange data. View the RVPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Reviva Pharmaceuticals Holdings, Inc. real time stock price chart below.
What Is the Reviva Pharmaceuticals Holdings, Inc. Stock Price Today?
The Reviva Pharmaceuticals Holdings, Inc. stock price today is 0.413.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings, Inc.?
The stock symbol for Reviva Pharmaceuticals Holdings, Inc. is "RVPH."
What Stock Exchange Does Reviva Pharmaceuticals Holdings, Inc. Trade On?
Reviva Pharmaceuticals Holdings, Inc. is listed and trades on the OTC Markets stock exchange.
Is Reviva Pharmaceuticals Holdings, Inc. a Good Stock to Buy?
Determining whether Reviva Pharmaceuticals Holdings, Inc., or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVPH quote. (ISIN: US76152G2093) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the Reviva Pharmaceuticals Holdings, Inc. Stock Price Today?
The Reviva Pharmaceuticals Holdings, Inc. stock price today is 0.413.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings, Inc.?
The stock symbol for Reviva Pharmaceuticals Holdings, Inc. is "RVPH."
What Stock Exchange Does Reviva Pharmaceuticals Holdings, Inc. Trade On?
Reviva Pharmaceuticals Holdings, Inc. is listed and trades on the OTC Markets stock exchange.
Is Reviva Pharmaceuticals Holdings, Inc. a Good Stock to Buy?
Determining whether Reviva Pharmaceuticals Holdings, Inc., or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RVPH quote. (ISIN: US76152G2093) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
0.413
-0.006(-1.43%)
Closed·
Fair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.380
0.450
52 wk Range
0.262
23.200
RVPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3800.450
52 wk Range
0.26223.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RVPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Reviva Pharmaceuticals Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
70.000
Upside
+16,849.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 70.000
(+16,849.15% Upside)
Earnings
Latest Release
May 13, 2026
EPS / Forecast
-0.46 / -0.05
Revenue / Forecast
-- / --
Compare RVPH to Peers and Sector
Metrics to compare | RVPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRVPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −7.5x | −0.5x | |
PEG Ratio | 0.00 | −0.41 | 0.00 | |
Price/Book | 0.3x | 1.9x | 2.6x | |
Price / LTM Sales | - | 6.1x | 3.1x | |
Upside (Analyst Target) | - | 115.8% | 53.0% | |
Fair Value Upside | Unlock | 13.4% | 6.3% | Unlock |
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Reviva Pharmaceuticals Holdings (RVPH) Stock Price Today?
The Reviva Pharmaceuticals Holdings stock price today is 0.413 USD.
What Stock Exchange Does Reviva Pharmaceuticals Holdings Trade On?
Reviva Pharmaceuticals Holdings is listed and trades on the OTC Markets.
What Is the Stock Symbol for Reviva Pharmaceuticals Holdings?
The stock symbol for Reviva Pharmaceuticals Holdings is "RVPH."
What Is the Reviva Pharmaceuticals Holdings Market Cap?
As of today, Reviva Pharmaceuticals Holdings market cap is 5.320M USD.
What Is Reviva Pharmaceuticals Holdings's Earnings Per Share (TTM)?
The Reviva Pharmaceuticals Holdings EPS (TTM) is -3.496.
When Is the Next Reviva Pharmaceuticals Holdings Earnings Date?
Reviva Pharmaceuticals Holdings will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is RVPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Reviva Pharmaceuticals Holdings Stock Split?
Reviva Pharmaceuticals Holdings has split 1 times.
How Many Employees Does Reviva Pharmaceuticals Holdings Have?
Reviva Pharmaceuticals Holdings has 14 employees.
What is the current trading status of Reviva Pharmaceuticals Holdings (RVPH)?
As of May 23, 2026, Reviva Pharmaceuticals Holdings (RVPH) is trading at a price of 0.413 USD, with a previous close of 0.419 USD. The stock has fluctuated within a day range of 0.380 USD to 0.450 USD, while its 52-week range spans from 0.262 USD to 23.200 USD.
What Is Reviva Pharmaceuticals Holdings (RVPH) Price Target According to Analysts?
The average 12-month price target for Reviva Pharmaceuticals Holdings is 70.000 USD, with a high estimate of 140 USD and a low estimate of 30 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +16,849.15% Upside potential.
What Is the RVPH Premarket Price?
RVPH's last pre-market stock price is 0.410 USD. The pre-market share volume is 2,850.000, and the stock has decreased by -0.009, or -2.150%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.